Patient-Focused Drug Development At 10: Where Does It Go From Here?
Executive Summary
FDA may conduct more than the 20 required meetings by the end of fiscal year 2017, but how will the patient-focused drug development program find its place in helping generate new drugs?
You may also be interested in...
FDA Considers Incorporating Patient Input In Generic Drug Assessments
The popular patient-focused drug development model for new drugs might not fit for generics, in part because the affected patient groups would be much larger.
US FDA Considers Incorporating Patient Input In Generic Drug Assessments
But the popular patient-focused drug development model for new drugs might not fit for generics, in part because the affected patient groups would be much larger.
Patient Advocates Continue To Push US FDA For Central Office
Will a meeting with the agency's new principal deputy commissioner help assure creation of new access point for patient engagement?